Renin-Inhibitors Market, New Developments, Current Growth Status
According to a new report from Intel Market Research , Global Renin-Inhibitors Market was valued at USD 89.2 million in 2024 and is projected to reach USD 145 million by 2032, growing at a CAGR of 7.4% during the forecast period (2025-2032). Download FREE Sample Report: https://www.intelmarketresearch.com/download-free-sample/12515/renin-inhibitors-market This growth trajectory reflects the sustained demand for innovative antihypertensive therapies in managing the global burden of hypertension. What are Renin-Inhibitors? Renin-Inhibitors represent a distinct class of pharmaceuticals that act directly on the renin-angiotensin-aldosterone system (RAAS), a key regulator of blood pressure and fluid balance. They function by inhibiting the activity of renin, a proteolytic enzyme released by the kidneys that initiates a cascade leading to increased blood pressure. Aliskiren (marketed under the trade names Tekturna in the US and Rasilez in other regions) is the first-in-class ...